Filter
1999
Filtered Results: 1999
Text search:
drug
regimens
Featured
Recommendations
206
New Publications
527
Language
Document type
No document type
1285
Guidelines
285
Studies & Reports
247
Manuals
62
Strategic & Response Plan
38
Fact sheets
35
Training Material
25
Situation Updates
7
Infographics
7
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
120
South Africa
64
Kenya
52
Global
49
Ethiopia
48
Tanzania
47
Western and Central Europe
42
Uganda
37
Nigeria
36
Zambia
34
Nepal
31
Eastern Europe
31
Rwanda
28
Africa
25
Latin America and the Carribbean
25
Malawi
24
Ghana
22
Ukraine
21
Liberia
20
Philippines
18
Bangladesh
18
Namibia
18
Myanmar / Burma
18
Asia
17
Zimbabwe
16
Cambodia
14
Sierra Leone
13
Mozambique
12
South–East Asia Region
12
Russia
12
Lesotho
11
Indonesia
11
Botswana
10
Eswatini/ Swaziland
8
Colombia
7
Thailand
7
Cameroon
7
Senegal
7
Congo, Democratic Republic of
6
Brazil
6
Albania
5
Haiti
5
Georgia
5
Tajikistan
4
Syria
4
USA
4
Venezuela
4
West and Central Africa
4
East and Southern Africa
4
Argentina
4
Pakistan
4
Benin
3
China
3
Estonia
3
Germany
3
Western Pacific Region
3
Jamaica
3
Vietnam
3
Bhutan
3
South Sudan
3
Timor Leste/ East Timor
2
Burkina Faso
2
Afghanistan
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Sri Lanka
2
Sudan
2
Romania
2
Iraq
2
Somalia
2
North Macedonia
1
North Korea
1
El Salvador
1
Gambia
1
Chile
1
Iran
1
Fiji
1
Laos
1
Peru
1
Morocco
1
Guinea
1
Jordan
1
Saudi Arabia
1
Middle East and North Africa
1
Denmark
1
Tunisia
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Papua New Guinea
1
Greece
1
Central African Republic
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
718
Clinical Guidelines
282
Public Health
86
Women & Child Health
70
Capacity Building
41
Key Resources
27
Pharmacy & Technologies
18
Toolboxes
TB
377
HIV
352
NTDs
91
AMR
78
Pharmacy
60
Mental Health
48
COVID-19
45
NCDs
45
Ebola & Marburg
29
Refugee
23
Caregiver
23
Rapid Response
16
Conflict
16
Polio
11
Disability
9
Health Financing Toolbox
7
Specific Hazards
4
Natural Hazards
4
Planetary Health
4
Malaria
4
Global Health Education
4
Cholera
3
Social Ethics
3
Zika
1
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO Guidelines for malaria supersedes 2 previous WHO publications: the Guidelines for the treatment of mala...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
The document discusses the complexities of managing patients with COPD and multiple comorbidities, highlighting the importance of personalized care and the appropriate use of inhaled corticosteroids (ICS). It outlines common comorbidities, such as asthma, osteoporosis, and diabetes, and offers guida...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Expert Consensus Validation 2018.
This innovative approach aimed at improving and facilitating the screening, prescribing and monitoring of drug therapy for older patients, is currently being further developed in the area of Clinical Pharmacology at the University of Heidelberg in Mannheim. This ap...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function of Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) in the UK. The previously described seven standards...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
